This inventor holds 21 USPTO granted patents, primarily in Pharmaceutical Chemistry. Top assignees: Astrazeneca Ab, Zeneca Limited, Ici Pharma S.a.. Active years: 1995-2007.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Congleton, GB (1995 - 2004)
- Macclesfield, GB (1999 - 2007)
Company Filing History:
10 out of 1,534 
10 out of 854 
1 out of 1 
Years Active: 1995-2007
Areas of Expertise:
Title: Gloria Anne Breault: Innovator in Anti-Cancer Pharmaceuticals
Introduction: Gloria Anne Breault, a distinguished inventor located in Macclesfield, GB, has significantly contributed to the field of pharmaceuticals through her innovative work in pyrimidine compounds. With a remarkable total of 21 patents to her name, her research primarily focuses on compounds with anti-cell proliferative activity, particularly in the area of cancer treatment.
Latest Patents: Among her latest inventions is a patent involving 2,4-diamino pyrimidine compounds that demonstrate anti-cell proliferative activity. This patent describes a pyrimidine derivative of formula (I), wherein substituents and structures promote their effectiveness as anti-cancer agents. Another notable patent involves pyrimidine derivatives that serve as cyclin-dependent serine/threonine kinase (CDK) inhibitors, essential in various pharmaceutical compositions aimed at treating cancer. These patents detail various medicinal uses and the processes for synthesizing these compounds.
Career Highlights: Gloria has made significant strides in her career while working with prominent pharmaceutical companies such as AstraZeneca and Zeneca Limited. Her research contributions have advanced understanding in the pharmaceutical sciences, especially in developing effective cancer treatments.
Collaborations: Throughout her career, Gloria has collaborated with esteemed professionals, including Janet Elizabeth Pease and Howard Tucker. These associations have fostered a collaborative environment that has led to groundbreaking developments in the pharmaceutical field.
Conclusion: Gloria Anne Breault's work embodies the spirit of innovation in the pharmaceutical industry, particularly in her contributions to anti-cancer agents through her extensive patent portfolio. Her dedication to research and development continues to inspire future advancements in medicine, proving essential for the ongoing battle against cancer.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile